Journal
CHEMICAL BIOLOGY & DRUG DESIGN
Volume 76, Issue 4, Pages 293-304Publisher
WILEY-BLACKWELL
DOI: 10.1111/j.1747-0285.2010.01021.x
Keywords
anti-adhesion vaccine; cross-reactive antibodies; Pseudomonas aeruginosa; synthetic peptide vaccine
Funding
- National Institute of Health [R01-AI 048717]
- John Stewart Chair in Peptide Chemistry
Ask authors/readers for more resources
One of the main challenges of Pseudomonas aeruginosa vaccine development is the design of an antigen that elicits cross-reactive antibodies against multiple virulent strains. Using a rational design approach, we have developed a single 17-residue peptide immunogen that generates antibodies that target the receptor-binding domain of the type IV pilus of more than one strain of P. aeruginosa. Using the receptor-binding domain sequence, of native strain PAO as a template, we have systematically changed up to five residues in the PAO sequence of the peptide immunogen into that of the PAK sequence. We show by indirect and competitive ELISA that the mutant peptide immunogens elicit the development of polyclonal sera that is cross-reactive to both native strain PAO and PAK pilin. We further show that there are at least two separate antibody populations in the polyclonal sera that possess closely related epitopes but which are each strain specific. Moreover, part of the epitope for the PAO-specific antibodies consists of several residues outside the disulfide loop of the receptor-binding domain. This allows us to create two unique epitopes within the same receptor-binding domain sequence.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available